Importance of atrial surface area and refractory period in sustaining atrial fibrillation: testing the critical mass hypothesis
- PMID: 22995722
- PMCID: PMC3966059
- DOI: 10.1016/j.jtcvs.2012.04.021
Importance of atrial surface area and refractory period in sustaining atrial fibrillation: testing the critical mass hypothesis
Abstract
Objective: The critical mass hypothesis for atrial fibrillation (AF) was proposed in 1914; however, there have been few studies defining the relationship between atrial surface area and AF. This study evaluated the effect of tissue area and effective refractory period (ERP) on the probability of sustaining AF in an in vivo model.
Methods: Domestic pigs (n = 9) underwent median sternotomy. Epicardial activation maps were constructed from bipolar electrograms recorded from form-fitting electrode templates placed on the atria. Baseline ERPs were determined. ERP was lowered with a continuous infusion of acetylcholine (0.005-0.04 mg/Kg/min) until AF could be sustained after burst pacing. The atria were sequentially partitioned using bipolar radiofrequency ablation. ERPs were lowered using acetylcholine until AF could be sustained in each subdivision of atrial tissue. Each subdivision was further divided until AF was no longer inducible. At study completion, the heart was excised and the surface area of each section was measured.
Results: Over a range of ERPs from 75 to 250 ms, the probability of AF was correlated with increasing tissue area (range, 19.5-105 cm(2)) and decreasing ERP. Logistic regression analysis identified shorter ERP (P < .001) and larger area (P = .006) as factors predictive of an increased probability of sustained AF (area under the curve of the receiver-operator characteristic = 0.878).
Conclusions: The probability of sustained AF was significantly associated with increasing tissue area and decreasing ERP. These data may lead to a greater understanding of the mechanism of AF and help to design better interventional procedures.
Keywords: 24; AF; CT; ECG; ERP; atrial fibrillation; computed tomography; effective refractory period; electrocardiogram.
Copyright © 2013 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.
Conflict of interest statement
RBS has received research grants from AtriCure, Inc. (West Chester, OH) and Estech, Inc (San Ramon, CA). RJD has received research grants from AtriCure, Inc., Estech, Inc., and Medtronic, Inc (Minneapolis, MN). RJD receives consultant fees from AtriCure, Inc. and Medtronic, Inc (Minneapolis, MN).
Figures
References
-
- Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, et al. Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009 Jan 27;119(3):e21–181. - PubMed
-
- Vidaillet H, Granada JF, Chyou PH, Maassen K, Ortiz M, Pulido JN, et al. A population-based study of mortality among patients with atrial fibrillation or flutter. Am J Med. 2002 Oct 1;113(5):365–70. - PubMed
-
- Garrey W. The nature of fibrillary contraction of the heart: its relation to tissue mass and form. American Journal of Physiology. 1914;33:397–414.
-
- Zou R, Kneller J, Leon LJ, Nattel S. Substrate size as a determinant of fibrillatory activity maintenance in a mathematical model of canine atrium. Am J Physiol Heart Circ Physiol. 2005 Sep;289(3):H1002–12. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
